Impact of Maternal BMI on Plasma Levels of Oxytocin During Labor Augmentation
1 other identifier
observational
40
1 country
1
Brief Summary
The aim of this study is to examine the associations between maternal BMI and levels of oxytocin in maternal plasma during augmentation with oxytocin during first stage of labor in term pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2019
CompletedFirst Posted
Study publicly available on registry
September 18, 2019
CompletedStudy Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedFebruary 21, 2021
February 1, 2021
2 months
September 14, 2019
February 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
maternal BMI, were weight and height will be combined to report BMI in kg/m^2
mass spectrometry
eight hours
level of oxytocin in plasma during oxytocin infusion
mass spectrometry
eight hours
Study Arms (1)
BMI, oxytocin
Repeteadly blood samples will be taken
Interventions
Eligibility Criteria
Full-term pregnancy (from gestational week 37+0), singel pregnancy, vertex presentation, knowledge in the Swedish language, 18 years and older, known BMI, need of labor augmentation with oxytocin infusion during opening stage.
You may qualify if:
- Full-term pregnancy (from gestational week 37+0), singel pregnancy, vertex presentation, knowledge in the Swedish language, 18 years and older, known BMI, need of labor augmentation with oxytocin infusion during opening stage.
You may not qualify if:
- Not participating in other studies at the delivery ward
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Obstetrics
Linköping, 58185, Sweden
Related Publications (1)
Ramo Isgren A, Carlhall S, Dennis Retrato M, Kodikara C, A Ubhayasekera K, Kjolhede P, Bergquist J, Blomberg M. The association between maternal body mass index and serial plasma oxytocin levels during labor. PLoS One. 2023 Aug 11;18(8):e0290038. doi: 10.1371/journal.pone.0290038. eCollection 2023.
PMID: 37566578DERIVED
Biospecimen
bloodplasma
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie Blomberg, PhD
Linkoeping University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 14, 2019
First Posted
September 18, 2019
Study Start
October 1, 2019
Primary Completion
December 1, 2019
Study Completion
August 1, 2020
Last Updated
February 21, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared with other researchers